Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

NCT02218164 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Skin
Carcinoma, Squamous Cell

Interventions

DRUG: Pegylated Interferon alpha-2b
DRUG: Capecitabine
DRUG: 5-FU

Sponsor

H. Lee Moffitt Cancer Center and Research Institute